Bingyi Lin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Hepatology top 10%
Papers in
-
- Glycosylation and Glycoproteins Research 6
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
-
- Galectins and Cancer Biology 4
- Immunotherapy and Immune Responses 4
- Co-authors
- Shusen Zheng (20 shared papers)Lei Geng (14 shared papers)Liming Wu (6 shared papers)Rong Cai (1 shared paper)Ling Tang (1 shared paper)Shuming Hu (1 shared paper)Wen Yi (8 shared papers)Lin Zhou (8 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)International Journal of Medical Sciences (3 papers)Cell Death and Differentiation (2 papers)World Journal of Gastroenterology (2 papers)Experimental Eye Research (1 paper)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Bingyi Lin
47 papers receiving 955 citations
Bingyi Lin's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 158
- Hepatology 71
- Transplantation 17
- Oncology 155
- Molecular Biology 395
Countries citing papers authored by Bingyi Lin
This map shows the geographic impact of Bingyi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyi Lin more than expected).
Fields of papers citing papers by Bingyi Lin
This network shows the impact of papers produced by Bingyi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyi Lin. The network helps show where Bingyi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingyi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NRF2, a Superstar of Ferroptosis Hit paper breakdown → | 2023 | 143 |
| 2 | 2019 | 94 | |
| 3 | 2023 | 86 | |
| 4 | 2001 | 61 | |
| 5 | 2019 | 59 | |
| 6 | 2018 | 43 | |
| 7 | 2022 | 38 | |
| 8 | 2021 | 34 | |
| 9 | 2014 | 32 | |
| 10 | 2021 | 32 | |
| 11 | 2017 | 31 | |
| 12 | 2014 | 28 | |
| 13 | 2015 | 25 | |
| 14 | 2024 | 24 | |
| 15 | 2006 | 23 | |
| 16 | 2014 | 20 | |
| 17 | 2024 | 19 | |
| 18 | 2022 | 19 | |
| 19 | 2014 | 19 | |
| 20 | 2018 | 14 |
About Bingyi Lin
Bingyi Lin is a scholar working on Molecular Biology, Immunology, Cancer Research, Surgery and Oncology, having authored 49 papers that have together received 965 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (6 papers), Galectins and Cancer Biology (4 papers), Immunotherapy and Immune Responses (4 papers), RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Ubiquitin and proteasome pathways (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). The work is most often cited by research in Cancer Research (158 citations), Hepatology (71 citations), Transplantation (17 citations), Oncology (155 citations) and Molecular Biology (395 citations). Bingyi Lin has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Shusen Zheng, Lei Geng, Liming Wu, Rong Cai, Ling Tang, Shuming Hu, Wen Yi, Lin Zhou, Qiang Zhu and Haiyang Xie. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Journal of Medical Sciences, Cell Death and Differentiation, World Journal of Gastroenterology and Experimental Eye Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.